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CASE REPORT
Toxic keratitis caused by topical abuse of anesthet-
ics is rare but can result in severe keratopathy, 
including persistent epithelial defect, Wessely-
type immune ring infiltration, disciform stromal
edema, Descemet’s membrane folding, and even
hypopyon.1–4 More serious is secondary infec-
tious keratitis or possible misdiagnosis as acan-
thamoeba keratitis caused by ring keratitis.3,4 We
report a case of bilateral toxic keratitis associated
with abuse of topical dilute 0.1% proparacaine
after laser subepithelial keratomileusis (LASEK)
surgery. After the prompt cessation of topical
proparacaine and initiation of treatment with
topical diluted 20% autologous serum, complete
corneal epithelialization was achieved within 
1 week, and the patient finally had good visual
recovery.
Case Report
A 26-year-old woman had bilateral high myopia
and wore soft contact lenses for 8 years. She under-
went bilateral LASEK surgery with 0.02% mito-
mycin C (MMC) soaking for 2 minutes. Bandage
contact lenses were applied to both eyes at the
end of surgery. Topical 0.3% ciprofloxacin and
0.1% fluorometholone four times daily were given.
One week postoperatively, the bandage contact
lenses were removed after complete corneal 
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Ring Keratitis Associated With Topical 
Abuse of a Dilute Anesthetic After 
Refractive Surgery
Yu-Chih Hou, I-Jong Wang, Fung-Rong Hu*
Anesthetic toxic keratitis is rare and presents as a ring keratitis, which is often misdiagnosed as
Acanthamoeba keratitis. Here, we report an unusual case of toxic keratitis caused by topical abuse of a di-
lute anesthetic. A 26-year-old woman presented with bilateral corneal edema, ring infiltrates, pigmented
keratic precipitate, Descemet’s membrane folding, and strong anterior chamber reactions 2 weeks after
laser subepithelial keratomileusis surgery. Tracing back her medical history, topical dilute 0.1% propara-
caine was prescribed and frequently used for 1 month. Toxic keratitis was suspected. After discontinuation
of the topical anesthetic and initiation of treatment with topical 20% autologous serum, complete corneal
epithelialization was achieved within 1 week. Corneal infiltrates and anterior chamber reaction gradually
subsided. Vision improved from finger counting to 20/20 in the right eye and 20/25 in the left eye, but
confocal microscopy showed decreased corneal endothelial cells. Topical abuse of a dilute topical anes-
thetic can cause severe toxic keratitis and endothelial cell loss. The physician must be aware of the signs of
topical anesthetic abuse and should not prescribe even a dilute anesthetic for long-term use. Autologous
serum can help in the recovery of toxic keratitis. [J Formos Med Assoc 2009;108(12):967–972]
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epithelialization. Unfortunately, corneal epithe-
lial defects and some peripheral infiltrates devel-
oped in both corneas 2 weeks postoperatively. She
felt pain and experienced photophobia. Bandage
contact lenses were applied again and topical
25 mg/mL amikacin and diclofenac four times
daily were given. However, corneal epithelial de-
fects and edema still increased, and topical 1%
prednisolone four times daily was added. Then,
peripheral infiltrates progressed to a ring shape
in both corneas. Numerous keratic precipitates and
marked anterior chamber reaction were also noted
4 weeks postoperatively. As a result of severe eye
pain and ring keratitis, she was referred to our
hospital with suspicion of Acanthamoeba keratitis.
On initial examination, she presented with bi-
lateral severe eye pain and photophobia. The pa-
tient’s vision was evaluated by finger counting at
50 cm in both eyes. Both eyelids were edematous,
and the conjunctiva was severely hyperemic. 
Slit-lamp biomicroscopic examination showed
an 8 × 8-mm disciform central corneal epithelial
defect, peripheral ring infiltrates, and diffuse
stromal edema in both eyes (Figures 1A and 1B).
There was marked folding in Descemet’s mem-
brane and numerous fine-pigmented keratic pre-
cipitates, with a strong anterior chamber reaction
(Figure 1C). Toxic keratitis was suspected. Tracing
back the patient’s medical history, topical dilute
anesthetic with 0.1% proparacaine was prescribed
for use as necessary to relieve eye pain after LASEK
surgery. The patient actually used the propara-
caine every 15 minutes for 1 month because 
of frequently intolerable pain. The topical 0.1%
proparacaine was refilled several times in the
clinic. Anesthetic abuse keratopathy was diagnosed.
Scraping smear examinations of both corneas
showed numerous polymorphonuclear cells with-
out any pathogens. Corneal cultures of bacteria,
fungi, Acanthamoeba and viruses were performed
on both eyes. Later, all cultures produced nega-
tive results except for small growth of Staphyloc-
occus epidermidis from the right eye, which might
have been caused by contamination. All the pre-
viously prescribed topical medications were dis-
continued. The patient was treated with topical
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Figure 1. (A, B) Slit-lamp biomicroscopic examination shows
a large central epithelial defect and ring-shaped infiltrates in
the right and left eye, respectively. (C) Numerous pigmented
keratic precipitates deposited on Descemet’s membrane, which
shows signs of folding.
sulfamethoxazole and preservative-free lubricant
four times daily, and 20% autologous serum
hourly. Autologous serum was prepared from a
total of 20 mL of the patient’s blood obtained by
venipuncture. The container was left standing for
2 hours at room temperature to ensure complete
clotting, and was centrifuged at 1500 rpm for 15
minutes. The supernatant serum was carefully
separated under sterile conditions and diluted by
normal saline to a concentration of 20%. It was
finally added to a 5-mL bottle and kept in a re-
frigerator. Oral diclofenac, 75 mg daily, was also
added to reduce eye pain. After treatment with
autologous serum, photophobia and eye pain
quickly reduced. Complete corneal epithelializa-
tion was achieved within 1 week and corneal infil-
trates were much reduced. Then, preservative-free
0.1% betamethasone was added four times daily.
Corneal edema and anterior chamber reaction
gradually diminished. After 2 weeks of treatment,
her eye pain and photophobia disappeared, and
the best-corrected visual acuity (BCVA) recovered
to 20/100 in both eyes. Confocal microscopy
(ConfoScan 3; Nidek Inc., Fremont, CA, USA)
showed decreased central corneal endothelial
cell density to 2128 cells/mm2 in the right eye
and 1024 cells/mm2 in the left eye. Corneal 
endothelial cells of both eyes revealed marked
pleomorphism and polymegathism, and were
interspersed with some white and glistening 
deposits that corresponded to clinical findings 
of pigmented keratic precipitates (Figures 2A 
and 2B). Nuclei of endothelial cells were more
prominent in the left eye, which indicated endothe-
lial cells in stress. Computerized videokerato-
graphic examination (TMS-1; Computed Anatomy
Inc., New York, NY, USA) revealed an uneven cor-
neal surface on both eyes, with a surface regularity
index (SRI) of 2.89 in the right eye and 6.28 in the
left eye. The surface asymmetric index (SAI) was
1.52 and 2.47 in the right and left eye, respectively.
All medications were tapered within 1 month.
Mild corneal haziness and a few keratic precipi-
tates were left and the BCVA improved to 20/40
in both eyes. One year later, there was only some
residual peripheral opacity and very faint central
haziness in both eyes. Corneal topography (TMS-4;
Tomey Corporation, Nagoya, Japan) showed a
smoother surface with an SRI of 0.21 and SAI of
1.43 in the right eye and an SRI of 0.56 and SAI
of 0.62 in the left eye. The BCVA was 20/20 with
−0.50/−0.75 × 140 in the right eye and 20/25
with + 0.5/−1.00 × 180 in the left eye. However,
corneal endothelial cell density was still decreased,
and measured 1906 cells/mm2 in the right eye
and 1176 cells/mm2 in the left eye.
Discussion
Topical 0.5% proparacaine is used commonly
during refractive surgery, but it is unusual to 
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Figure 2. (A, B) Confocal microscopy revealed that central corneal endothelial cell density decreased to 2128 cells/mm2
in the right eye and 1024 cells/mm2 in the left eye. Marked pleomorphism and polymegathism occurred in the endothe-
lial cells and some highly reflective deposits are observed. Nuclei of endothelial cells were more prominent in the left
than the right eye.
prescribe diluted proparacaine for the manage-
ment of pain after excimer photokeratectomy. The
early presenting signs of topical anesthetic abuse
include persistent epithelial defects and stromal
infiltrate.1,2 Ring infiltration, keratic precipitates,
and endothelial loss can occur within days to
weeks of onset. Furthermore, the signs and symp-
toms related to topical anesthetic abuse can mas-
querade as Acanthamoeba keratitis because of
similarities such as disproportionate pain, use of
bandage contact lenses, and corneal ring infiltra-
tion, such as in our case.3,4 In fact, the differential
diagnosis for ring infiltrate is quite broad, and
includes herpes simple keratitis, Gram-negative
bacterial keratitis, fungal keratitis, and mycobac-
terial keratitis.3,4 Persistent epithelial defects can
give an opportunity for superimposed infection,
which can interfere with diagnosis and increase
the difficulty of treating toxic keratitis. Smears
and cultures of acanthamoeba and other patho-
gens should be obtained to rule out any possible
superinfection. Delayed diagnosis of toxic anes-
thetic keratitis can result in corneal perforation
and severe loss of vision.4
Several mechanisms involved in the patho-
genesis of keratopathy and the adverse effects of
topical anesthetics have been proposed.1–5 Topical
anesthetics can cause unstable tear film by de-
creased aqueous reflex tear production and dimin-
ished mucous adherence because of disruption
of the microvilli of epithelial cells. Tear film in-
stability, decreased reflex tearing, and a reduced
blink rate combine to cause an increased rate of
tear evaporation, which leads to more dryness
and epithelial damage. Anesthetic interferes with
epithelial metabolism by impairing the trophic
function of the corneal nerve fibers. This results
in intolerable pain of the insensitive cornea,
which can force the patient to apply the anes-
thetic more frequently and cause a vicious cycle.
Topical anesthetic can cause punctate epithelial
keratopathy and affect cell migration and division.
The delayed epithelial wound healing and per-
sistent epithelial defects are noted in epithelial
toxicity.3 Proparacaine inhibits corneal epithelial
migration and adhesion through alteration of the
actin cytoskeleton. Dissociation of vinculin-based
epithelial cell motility complexes can cause the
release of another factor that can serve as an anti-
gen.4,5 Immune recognition of this antigen might
be responsible for the ring infiltrate. When ep-
ithelium is absent, the toxic effect of anesthetic
can be enhanced markedly by direct exposure to
the keratocytes of the corneal stroma. The toxic
effects of direct exposure to the keratocytes in-
clude stromal infiltration, edema, and melting.
Corneal stromal melting can cause corneal surface
irregularity and haziness. Adverse effects of en-
dothelial toxicity include endothelial pleomor-
phism, focal endothelial necrosis, cell loss, and
numerous filamentous processes emanating from
abnormally enlarged intracellular junctions.6 We
believe that the major cause of endothelial cell
loss in this patient was not so much related to her
previous contact lenses wearing as to long-term
abuse of dilute topical anesthetics. Direct toxic
effects of or indirect immune reactions to topical
anesthetics can also result in severe inflammation
in the anterior chamber and keratic precipitates,
which can cause further endothelial cell loss. In
our case, more endothelial cell loss in the left than
the right eye might have been caused by a different
frequency of topical anesthetic abuse in both eyes,
because of the presence of more keratic precipi-
tates and stressed cells in the left eye.
Preservatives, such as 0.1% benzalkonium
chloride (BAC) in proparacaine, are also toxic to
corneal and conjunctival epithelium.7 The fre-
quent application of medication that contains
0.004% BAC can cause severe endothelial dam-
age.8 In addition to the long-term and frequent
use of topical anesthetic in our case, the accumula-
tive toxicity of BAC also could have contributed
to corneal necrosis, thereby enhancing the toxicity
of topical anesthetic.
Ethanol is used in the creation of the epithelial
flap in LASEK surgery. Diluted ethanol induces
an inflammatory response, corneal edema, and
polymorphonuclear cell infiltration to the corneal
stroma.9 Adverse effects of ethanol in keratocytes
include breaking intercellular adhesion, apoptosis,
and cell loss.10 MMC has been used to reduce
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corneal haze and remove subepithelial fibrosis
in photorefractive keratectomy or LASEK surgery
but can cause corneal edema.11,12 The long-term
use of topical MMC in pterygium surgery has been
reported to cause severe ocular complications, in-
cluding secondary glaucoma, corneal edema, cor-
neal perforation, and iritis.13 In a rabbit model,
delayed epithelialization, corneal edema, decreased
endothelial density, and increased endothelial
apoptosis have been observed upon application
of 0.02% MMC for 2 minutes.14 MMC induces
apoptosis in keratocytes and has latent effects
within the intracellular or extracellular enviro-
ment.10 Co-treatment with ethanol and MMC has
shown synergistic damage in cultured corneal fi-
broblasts.10 In our case, diluted ethanol and 0.02%
MMC for 2 minutes in LASEK surgery could have
worsened anesthetic toxic keratopathy as a result
of these adverse effects in corneal keratocytes
and endothelial cells.
Serum contains epidermal growth factor (EGF),
acidic and basic fibroblast growth factor (aFGF
and bFGF), transforming growth factor (TGF) β,
fibronectin, vitamin A, antiprotease, and neural fac-
tors.15 Autologous serum can accelerate the mi-
gration of corneal epithelial cells and help healing
of corneal epithelial defects. EGF is present in tears
and serum and has antiapoptotic properties.15,16
Additionally, EGF, aFGF, bFGF and fibronectin
have been found to facilitate epithelialization.17,18
Serum antiprotease such as α2 macroglobulin in-
hibits corneal collagenase and decreases corneal
melting.19 These beneficial effects of autologous
serum might have contributed to rapid epithelial-
ization and less corneal melting in our case. Auto-
logous serum also harbors several neurotrophic
factors, such as nerve growth factor, substance P,
and insulin-like growth factor, and has been used
to treat neurotrophic keratopathy.20 These neural
factors induce neurite sprouting by neural cells
and restore the function of injured neurons, there-
fore, autologous serum also can help regenera-
tion of neurotrophic keratopathy caused by toxic
anesthetic abuse.
Once the abuse of topical anesthetics has been
diagnosed, the management of such a patient is
cessation of use of the offending agent. In all cases,
topical treatment of the vulnerable cornea should
be kept to a minimum. Most cases with minor
manifestations will resolve rapidly. Depending on
the severity of the epithelial defect, preservative-
free lubricants, patching, therapeutic contact lenses,
collagen shields, and tarsorrhaphy have been
suggested to facilitate healing of the epithelial
defects and arrest destruction of the stroma.2,4
Severe or persistent corneal melting might require
a conjunctival flap or amniotic membrane graft.
In some instances, penetrating keratoplasty could
be required to save vision, such as in cases with
risk of corneal perforation or severe vision loss
caused by corneal scarring and opacity. Most re-
ported cases of toxic anesthetic keratitis with ini-
tially poor vision have been reported to have a
long and poor visual recovery from no light per-
ception to 20/80.1–4,7 Some cases have required
penetrating keratoplasty to restore vision.2,4,6 In
rare instances, enucleation has been carried out
in patients with no visual potential.4 Chen et al
reported that topical abuse of even a dilute anes-
thetic, 0.05% oxybuprocaine, could cause severe
toxic keratitis, which led to poor vision.21 The good
visual recovery in our case of severe toxic keratitis
could have been because of early cessation of anes-
thetic and adjuvant application of autologous
serum, although we did not perform a compara-
tive treatment in each eye.
The physician must be aware of the signs of
topical anesthetic abuse and consider it in the
differential diagnosis of patients with chronic 
recalcitrant keratitis, especially with corneal ring
infiltrates. Long-term topical abuse of dilute
anesthetic can still cause severe toxic keratitis
and permanent endothelial cell loss. Cytotoxicity
of ethanol and MMC can exacerbate anesthetic
toxic keratitis and should be taken into consid-
eration in their use for refractive surgery. Con-
clusively, early diagnosis of toxic keratitis and
discontinuation of the anesthetic agent is a key
factor for saving vision. Autologous serum may
accelerate reepithelialization of persistent epi-
thelial defects and regeneration of neurotrophy,
and decrease corneal scarring formation in toxic
Topical anesthetic abuse-induced toxic keratitis
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keratitis. The temptation for anesthetic abuse is
great; therefore, we recommend that the prescrip-
tion of even a dilute topical anesthetic should be
very cautious, and it should not be allowed for
long-term usage.
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